Evidence map›Paper›PMID 34261450›Full record

ArticleBMC infectious diseases2021

Genomic surveillance of antimicrobial resistant bacterial colonisation and infection in intensive care patients.

Kelly L Wyres, Jane Hawkey, Mirianne Mirčeta, Louise M Judd, Ryan R Wick, Claire L Gorrie, Nigel F Pratt, Jill S Garlick, Kerrie M Watson, David V Pilcher and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Kelly L Wyres *Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia. kelly.wyres@monash.edu.
Jane Hawkey *Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Mirianne MirčetaMicrobiology Unit, Alfred Health, Melbourne, Victoria, Australia.
Louise M JuddDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Ryan R WickDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Claire L GorrieDepartment of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria, Australia.
Nigel F PrattInfectious Diseases Clinical Research Unit, The Alfred Hospital, Melbourne, Victoria, Australia.
Jill S GarlickInfectious Diseases Clinical Research Unit, The Alfred Hospital, Melbourne, Victoria, Australia.
Kerrie M WatsonInfectious Diseases Clinical Research Unit, The Alfred Hospital, Melbourne, Victoria, Australia.
David V PilcherIntensive Care Unit, The Alfred Hospital, Melbourne, Victoria, Australia.
Steve A McGloughlinIntensive Care Unit, The Alfred Hospital, Melbourne, Victoria, Australia.
Iain J AbbottDepartment of Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia.
Nenad MacesicDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Denis W SpelmanDepartment of Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia.
Adam W J JenneyMicrobiology Unit, Alfred Health, Melbourne, Victoria, Australia. a.jenney@alfred.org.au.
Kathryn E HoltDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
The Alfred Hospital · AUMonash University · AUAlfred Health · AULondon School of Hygiene & Tropical Medicine · GBUniversity of Melbourne · AU

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundThird-generation cephalosporin-resistant Gram-negatives (3GCR-GN) and vancomycin-resistant enterococci (VRE) are common causes of multi-drug resistant healthcare-associated infections, for which gut colonisation is considered a prerequisite. However, there remains a key knowledge gap about colonisation and infection dynamics in high-risk settings such as the intensive care unit (ICU), thus hampering infection prevention efforts.

methodsWe performed a three-month prospective genomic survey of infecting and gut-colonising 3GCR-GN and VRE among patients admitted to an Australian ICU. Bacteria were isolated from rectal swabs (n = 287 and n = 103 patients ≤2 and > 2 days from admission, respectively) and diagnostic clinical specimens between Dec 2013 and March 2014. Isolates were subjected to Illumina whole-genome sequencing (n = 127 3GCR-GN, n = 41 VRE). Multi-locus sequence types (STs) and antimicrobial resistance determinants were identified from de novo assemblies. Twenty-three isolates were selected for sequencing on the Oxford Nanopore MinION device to generate completed reference genomes (one for each ST isolated from ≥2 patients). Single nucleotide variants (SNVs) were identified by read mapping and variant calling against these references.

resultsAmong 287 patients screened on admission, 17.4 and 8.4% were colonised by 3GCR-GN and VRE, respectively. Escherichia coli was the most common species (n = 36 episodes, 58.1%) and the most common cause of 3GCR-GN infection. Only two VRE infections were identified. The rate of infection among patients colonised with E. coli was low, but higher than those who were not colonised on admission (n = 2/33, 6% vs n = 4/254, 2%, respectively, p = 0.3). While few patients were colonised with 3GCR- Klebsiella pneumoniae or Pseudomonas aeruginosa on admission (n = 4), all such patients developed infections with the colonising strain. Genomic analyses revealed 10 putative nosocomial transmission clusters (≤20 SNVs for 3GCR-GN, ≤3 SNVs for VRE): four VRE, six 3GCR-GN, with epidemiologically linked clusters accounting for 21 and 6% of episodes, respectively (OR 4.3, p = 0.02).

conclusions3GCR-E. coli and VRE were the most common gut colonisers. E. coli was the most common cause of 3GCR-GN infection, but other 3GCR-GN species showed greater risk for infection in colonised patients. Larger studies are warranted to elucidate the relative risks of different colonisers and guide the use of screening in ICU infection control.

Indexed as

Cross InfectionEscherichia coliInfection ControlIntensive Care UnitsVancomycin-Resistant EnterococciAnti-Bacterial AgentsAustraliaCephalosporin ResistanceDrug Resistance, Multiple, BacterialGastrointestinal TractHumansProspective StudiesAnti-Bacterial AgentsAntimicrobial resistance (AMR)ColonisationGenomic surveillanceIntensive careTransmission

Identifiers

PMID34261450
PMCPMC8278603
OpenAlexW3106198678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.